Estrogen receptor α polymorphisms and postmenopausal breast cancer risk
✍ Scribed by A. M. González-Zuloeta Ladd; A. Arias Vásquez; F. Rivadeneira; C. Siemes; A. Hofman; B. H. Ch. Stricker; H. A. P. Pols; A. G. Uitterlinden; C. M. van Duijn
- Publisher
- Springer US
- Year
- 2007
- Tongue
- English
- Weight
- 291 KB
- Volume
- 107
- Category
- Article
- ISSN
- 0167-6806
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Estrogens exert their effect on the breast through the estrogen receptor. We prospectively investigated breast cancer risk associated with 2 polymorphic sites in the estrogen receptor alpha gene (__ESR1__). A total of 4,248 Caucasian women from the Study of Osteoporotic Fractures were g
## Abstract Lignans are a group of estrogenic compounds present in plants. Several epidemiological studies proposed that lignans may protect against breast cancer by exerting anticarcinogenic activity. Levels of enterolactone were determined in serum samples of 1,250 cases and 2,164 controls from a
## Abstract Hormone therapy (HT) and body mass index (BMI) have been associated with postmenopausal breast cancer. Because estrogen metabolism may affect breast cancer risk and can be altered by weight and HT, it might play a role in the HT–BMI–breast cancer associations. We undertook a nested case